Autoimmune / Chronic Fatigue Management
Chronic Fatigue Immune Dysfunction Syndrome, also known as Chronic Fatigue Syndrome (CFS) and Myalgic Encephalomyelitis (ME) is one of the more common autoimmune diseases that currently affects more than 1 million Americans each year. There is currently no single test to confirm a diagnosis of CFS and the cause is unknown. Some theories associate CFS being caused by chronic mitochondrial dysfunction, viral infections, immune system impairment, and hormonal imbalances.
Age Management’s Autoimmune / CFS Treatment Program uses a multifaceted treatment model to address the wide range of underlying symptoms that are associated with chronic fatigue syndrome. Using this integrated approach, Age Management develops and individualized, comprehensive treatment plan for patients that utilize the latest and most effective treatment options available to reduce and eliminate chronic fatigue syndrome symptoms.
Research has shown that mitochondria dysfunction is directly correlated as a cause of CFS symptoms. Mitochondria are responsible for the production of ATP which is the primary fuel source for all cells in the body. Dysfunctional mitochondria are unable to produce ATP and recycle ADP to replenish the body’s ATP supplies and needs. Age Management uses key mitochondrial nutrients and antioxidants to promote cellular detoxification and support mitochondria rejuvenation. Patients notice a rapid improvement in energy, alertness, and concentration along with a gradual improvement in functional status.
With 70% of the body’s immune system directly related to the gastrointestinal system, the GI system is an underlying factor towards the development of a large number of chronic and autoimmune disease states. Age Management recognizes the importance of a healthy and fully functioning GI system to effectively treat and heal patients of disease while building a strong immune system for life long disease prevention.
Brain dysfunction has been documented in EEG research in a high percentage of patients with CFS/ME. LENS Neurofeedback is a process that optimizes brain performance through stimulation and self-regulation of brain wave activity. As brain health and self-regulation occurs a wide variety of chronic fatigue symptoms associated with brain and central nervous system dysfunction start to improve. As self-regulation occurs we see an increase in cognitive functioning, motivation, motor skills, mood regulation, decreased anxiety, improved sleep, increased energy and stamina, decrease in seizure and explosiveness, reduce headache symptoms, and decreased restless leg and muscle problems.
As we age, a cascade of hormones including Estrogen, Progesterone, and Testosterone, and Thyroid gradually begin to decline. Many symptoms of fibromyalgia are similar to those of hormone deficiencies which include fatigue, chronic pain, inflammation, muscle weakness, sleep issues, and mood disorders. Lab work to check sex hormones and cortisol will determine if a deficiency may be a contributing factor to fibromyalgia symptoms.
Intravenous nutrient therapy is a way to introduce vitamins, minerals, amino acids, and therapeutic agents directly in the bloodstream to correct deficiencies, enhance immune system function, increase energy, decrease inflammation, and promote healing and recovery. The benefit of IV therapy over oral nutrition is that nutrients bypass the digestive system for 100% absorption in high concentrations to optimally nourish the body’s cells and tissues. IV nutrient therapy creates an environment of higher than normal levels of specific nutrients that have been shown in scientific literature to be effective in treatment of a wide variety of symptoms and conditions.
Physician grade supplements are used to support a wide range of physiological processes in the body to promote energy production, decrease inflammation, strengthen immune system function, and promote healing and recovery.
Low Dose Naltrexone has been used for decades to decrease pain and increase immune system function. LDN has demonstrated to moderately reduce symptoms of muscle weakness and fatigue associated with chronic fatigue syndrome. Evidence shows that LDN operates as an anti-inflammatory agent in the central nervous system, via its action on microglial cells. LDN increases beta endorphin opioids that strengthen the immune system by increasing natural killer cell counts which are shown to be impaired in CFS/ME.